Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
about
Antiplatelet resistance in strokeCurrent status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implicationsPersonalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Assessment of platelet inhibition by point-of-care testing in neuroendovascular proceduresThe prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysisHigh residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistancePharmacogenomics and cardiovascular diseasePlatelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysisClarity and strength of implications for practice in medical journal articles: an exploratory analysisEfficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled TrialsInhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients.Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromesInhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel.Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?Increased platelet reactivity is associated with circulating platelet-monocyte complexes and macrophages in human atherosclerotic plaques.Mutational analysis clopidogrel resistance and platelet function in patients scheduled for coronary artery bypass grafting.Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic eventsClopidogrel "resistance": where are we now?Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.Clinical importance of aspirin and clopidogrel resistanceOmega-3 fatty acids modulate collagen signaling in human platelets.Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?Platelet function tests: a comparative review.A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD studyThe genetics of common variation affecting platelet development, function and pharmaceutical targeting.Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspectiveMonitoring the effectiveness of antiplatelet therapy: opportunities and limitations.Effect of gender difference on platelet reactivity.Genome-wide association study of platelet aggregation in African Americans
P2860
Q22305927-49AABB06-7685-4457-BA80-57A9DA285373Q26771106-228FD1BA-95F2-4BCA-8B83-AB85ED9A13F6Q26775125-20130E2C-4F54-446A-9F7F-F3DE7F1401D6Q26823542-6FB5D5A9-81A5-4B2F-A210-8EA706A5288CQ26823633-4E0FA804-DF9F-41A6-A1F5-AEFA4BC10106Q26824694-6E353269-F693-4BF4-B0FB-2B18324D5DD2Q26824850-7EAC817C-B77E-48D9-9B71-3D4E78CF8FB2Q26997380-B1E2C31E-A3D4-417A-9EF0-4553DEF55592Q27010236-FF2FE990-B220-47FB-940C-56EC63A26610Q28387287-E429BB12-87B7-44A1-AD4C-BB08318DE771Q28548148-BF7BB836-B8BA-4ABD-9094-1FB11F9DD3EFQ33414182-C6712BFC-135B-4912-BD0E-30D2A4219F00Q33636020-D31F8F5B-DF63-41C4-8778-552766A80C00Q33637814-E393F858-790F-4C69-9C91-36E743A0508BQ33637824-B8F8AFC6-3E5A-4A28-A820-B7F891A00EC8Q33637840-99CAD3E5-35C1-4211-967B-18055BC7D4E2Q33760007-35E9F626-6330-43F0-A76E-C29478C8CD73Q33804996-A94CF28F-0547-4254-98EF-1378D9BD65CBQ33923341-693508B0-ECE4-455D-B958-450537BB9D7FQ33963651-2A855AB1-8FC2-4EB3-9188-A3DE328C6B67Q33982372-189E6702-D023-4677-8E3B-00A668713CD7Q33997642-23915B3C-599A-4634-AD8A-0BE5617F6D29Q34014099-098B5F82-4A23-4544-A1D2-9E4C0E2E213DQ34035039-9DE28F57-802F-477E-B7A9-4ACF431C1E7DQ34047367-306117DE-FE5E-4187-9A02-A0252816C43EQ34108764-53F48844-9698-4015-977B-36ECF667E247Q34111144-FB19B2AD-590E-4C71-A4ED-06D60DC6C7C9Q34212563-7975E450-CC57-4C1E-BF12-BBC491C66152Q34374101-FAD2550A-CF12-47F0-A109-7AC02E02D703Q34390050-BAB99313-5842-48F9-B25D-3B0EF28DFDFFQ34543177-6885D2B2-90E1-45C7-95A7-965F4860A279Q34624862-769D4D7A-27B1-4D30-9524-EB835A146BC6Q35035904-3C3E9313-E7CD-41D3-AE1E-4A3769BA6756Q35121464-724FBC94-E868-40AB-AC87-8CB2F505E023Q35126038-20090C3E-6F7E-4685-A101-D673BD925FF6Q35149898-22AB2704-9013-4559-A6CC-8D7C54092FECQ35174193-8D75ABC8-AB58-42E0-89F5-E1CB9CA9FBBBQ35373683-C9FD84E0-948B-43BF-8BBF-0ACBA12B8003Q35473568-F1790EE4-A7A4-4923-B95F-267047AC6F35Q35646500-58A847B2-8E9B-4742-919C-AC08B9AD1106
P2860
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Comparison of platelet functio ...... g coronary stent implantation.
@en
type
label
Comparison of platelet functio ...... g coronary stent implantation.
@en
prefLabel
Comparison of platelet functio ...... g coronary stent implantation.
@en
P2093
P356
P1476
Comparison of platelet functio ...... g coronary stent implantation.
@en
P2093
Ankie M Harmsze
Benno J W M Rensing
Christian M Hackeng
Egbert T Bal
Heleen J Bouman
Henk J T Ruven
Jan A S van der Heyden
Jochem W van Werkum
Johannes C Kelder
Jurriën M ten Berg
P304
P356
10.1001/JAMA.2010.181
P407
P577
2010-02-01T00:00:00Z